Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: A Phase 1/2 Study of CAN04 in Combination With Different Chemotherapy Regimens in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of CAN04 in combination with various chemotherapy regimens for advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Study of Tarloxotinib in Pts With NSCLC (EGFR Exon 20 Insertion, HER2-activating Mutations) & Other Solid Tumors With NRG1/ERBB Gene Fusions [Phase 2]
Phase 2 study of tarloxotinib in NSCLC with EGFR Exon 20 insertion or HER2-activating mutations and other solid tumors with NRG1/ERBB fusion…
-
CLINICAL_TRIALS trial_result · 2023-06-26Clinical Trial Update: Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLC [Phase 1, Phase 2]
Phase 1/2 trial updates for dose-escalation of RMC4630 with cobi in relapsed/refractory solid tumors and RMC4630 with osi in EGFR+ locally a…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Phase III Study Evaluating Efficacy and Safety of Canakinumab in Combination With Docetaxel in Adult Subjects With Non-small Cell Lung Cancers as a Second or Third Line Therapy [Phase 3]
Phase III trial evaluating canakinumab with docetaxel in adults with non-small cell lung cancer as second or third-line therapy; study termi…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Plasmodium Immunotherapy for Lung Cancer [Phase 1, Phase 2]
A clinical trial update on a plasmodium immunotherapy approach for lung cancer, currently in Phase 1 and Phase 2.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab. [Phase 4]
A Phase 4 trial investigating mobile devices to detect early pneumonitis in unresectable Stage III non-small cell lung cancer patients treat…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study) [Phase 1, Phase 2]
Pfizer sponsored a Phase 1/2 landscape trial evaluating sasanlimab in combination with targeted therapies for advanced non-small cell lung c…
-
FDA approval · 2023-06-21FDA Approved: TAGRISSO — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approves a supplemental application for Tagrisso (osimertinib) submitted by AstraZeneca, resulting in updated labeling and/or an expande…
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Study of Safety and Efficacy of EGFR-TKI EGF816 in Combination With cMET Inhibitor INC280 in Adult Patients With EGFR Mutated Non Small Cell Lung Cancer. [Phase 1, Phase 2]
A Phase 1/2 study evaluating EGFR-TKI EGF816 (osimertinib) in combination with the cMET inhibitor INC280 for adults with EGFR-mutated non-sm…
-
FDA approval · 2023-06-16FDA Approved: CARBOPLATIN — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.'s supplemental application for generic carboplatin. This action permits Apotex to market a generic carboplatin for…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Can Not Be Surgically Removed [Phase 3]
Phase 3 trial evaluating combination chemotherapy plus radiation therapy for unresectable stage III non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: A Study of CS1001 in Subjects With Stage III Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 clinical trial of CS1001 in subjects with stage III non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy in patients with advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial comparing two combination chemotherapy regimens for treating lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION) [Phase 2]
Phase 2 trial update of durvalumab in frail and elderly patients with metastatic non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: A Study to Investigate Atezolizumab Subcutaneous in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating subcutaneous atezolizumab in previously treated locally advanced or metastatic non-small cell lung cancer has compl…
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy [Phase 2]
Phase 2 trial update for ADMIRAL evaluating adaptive mediastinal radiation with chemo-immunotherapy in locally advanced non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: Abscopal Effect of Radiation in Combination With rhGM-CSF for Metastatic Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating the abscopal effect of radiation in combination with rhGM-CSF for metastatic non-small cell lung cancer has complet…
-
CLINICAL_TRIALS trial_result · 2023-06-12Clinical Trial Update: Anlotinib After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer（ALTER-L029） [Phase 2]
Phase 2 trial evaluating anlotinib after chemoradiotherapy in stage III non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-12Clinical Trial Update: Efficacy and Safety of HL-085 Combined With Vemurafenib in BRAF V600E Patients With Non-small Cell Lung Cancer: a Phase II Clinical Study [Phase 2]
Phase II clinical trial evaluating HL-085 with vemurafenib in patients with BRAF V600E–mutant non-small cell lung cancer to assess efficacy …
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION) [Phase 2]
Phase II trial update (VISION) evaluating Tepotinib in advanced non-small cell lung cancer with MET alterations; results were posted in 2023…
-
CLINICAL_TRIALS trial_result · 2023-06-07Clinical Trial Update: Precision-exercise-prescription for Lung Cancer Patients Undergoing Surgery: The PEP Study [Phase 3]
Phase 3 trial investigating precision exercise prescription for lung cancer patients undergoing surgery has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-06Clinical Trial Update: An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 exploratory trial evaluating the combination of nivolumab and ipilimumab in treatment-naive stage IV or recurrent non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC [Phase 1]
Phase 1 trial of atezolizumab and varlilumab with radiation therapy in refractory stage IV non-small cell lung cancer was terminated, with r…
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors [Phase 1, Phase 2]
A dose-escalation with expansion study of EMB-01 in advanced/metastatic solid tumors is underway across Phase 1 and Phase 2.